You have 9 free searches left this month | for more free features.

TIM-3

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Solid Tumor Trial in China (TQB2618 injection and TQB2450 injection)

Recruiting
  • Advanced Solid Tumor
  • TQB2618 injection and TQB2450 injection
  • Fuzhou, Fujian, China
  • +4 more
Dec 1, 2022

Metastatic Melanoma Trial in New Haven (Tumor Infiltrating Lymphocytes, Nivolumab and Ipilimumab)

Terminated
  • Metastatic Melanoma
  • Tumor Infiltrating Lymphocytes
  • Nivolumab and Ipilimumab
  • New Haven, Connecticut
    Yale New Haven Hospital
Jul 20, 2022

Neuroimaging, Quality Control Trial in Ghent (Magnetic Resonance Imaging)

Completed
  • Neuroimaging
  • Quality Control
  • Magnetic Resonance Imaging
  • Ghent, Belgium
    Ghent University
Nov 30, 2021

Solid Tumor Trial in Belgium, Japan, United States (LY3415244)

Terminated
  • Solid Tumor
  • Boston, Massachusetts
  • +5 more
Oct 21, 2021

Advanced Solid Tumors Trial in Hangzhou (TQB2618 injection)

Unknown status
  • Advanced Solid Tumors
  • TQB2618 injection
  • Hangzhou, Zhejiang, China
    Cancer Hospital of The University of Chinese Academy of Sciences
Nov 8, 2020

MRI Assessment of Leukemia Response to Therapy

Completed
  • Acute Myelogenous Leukemia
  • 3 Tesla (3T) Siemens Total imaging matrix (TIM) Trio whole-body system
  • Portland, Oregon
    Oregon Health and Science University
Jul 27, 2019

Autoimmune Diseases, Multiple Sclerosis Trial in Amman (LPX-TI641)

Not yet recruiting
  • Autoimmune Diseases
  • Multiple Sclerosis
  • Amman, Jordan
    Triumpharma
May 11, 2023

Advanced Esophageal Squamous Cell Carcinoma Trial in China (TQB2618 injection, Penpulimab injection, Paclitaxel, Cisplatin,

Not yet recruiting
  • Advanced Esophageal Squamous Cell Carcinoma
  • TQB2618 injection, Penpulimab injection, Paclitaxel, Cisplatin
  • +2 more
  • Tongling, Anhui, China
  • +9 more
Apr 18, 2023

Postoperative Prevention of Tumor Trial in Shanghai (Oral NMN combined with DC cell vaccine)

Not yet recruiting
  • Postoperative Prevention of Tumor
  • Oral NMN combined with DC cell vaccine
  • Shanghai, Shanghai, China
    Shanghai Mengchao Cancer Hospital
Sep 6, 2023

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine, PDR001, MBG453)

Active, not recruiting
  • Leukemia
  • +7 more
  • Boston, Massachusetts
  • +10 more
Jan 19, 2023

Acute Myeloid Leukemia (AML), High-risk Myelodysplastic Syndrome (MDS) Trial in Worldwide (HDM201, MBG453, Venetoclax)

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • High-risk Myelodysplastic Syndrome (MDS)
  • Durham, North Carolina
  • +8 more
Dec 13, 2022

Nasopharyngeal Carcinoma Trial in China (TQB2618 Injection, Pempulimab Injection, Cisplatin Injection, Gemcitabine Hydrochloride

Recruiting
  • Nasopharyngeal Carcinoma
  • TQB2618 Injection, Pempulimab Injection, Cisplatin Injection, Gemcitabine Hydrochloride Injection
  • +2 more
  • Guangzhou, Guangdong, China
  • +3 more
Nov 28, 2022

Recurrent/Refractory Acute Myeloid Leukemia, MDS Trial in ChengDu (TQB2618 injection azacitidine, AZA decitabine, DAC)

Recruiting
  • Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes
  • TQB2618 injection azacitidine, AZA decitabine, DAC
  • ChengDu, Sichuan, China
    West China Hospital of Sichuan University
Jun 16, 2022

NSCLC Trial in Guangzhou (Hypofractionated radiotherapy, induction chemo-immunotherapy, concurrent chemo)

Recruiting
  • Non-small Cell Lung Cancer
  • Hypofractionated radiotherapy
  • +4 more
  • Guangzhou, Guangdong, China
    Sun yat-sen university cancer center
Nov 14, 2023

Breast Cancer Trial in Istanbul (Soluble immune checkpoints)

Recruiting
  • Breast Cancer
  • Soluble immune checkpoints
  • Istanbul, Turkey
  • +1 more
Jul 14, 2022

Crosstalk Between Mucosal-Associated Invariant T Cells and Gut

Recruiting
  • Type1diabetes
  • MAIT cells analysis
  • +4 more
  • Antony, France
  • +1 more
Aug 2, 2022

Immune Dysregulation in Patients With COVID-19

Recruiting
  • COVID-19
  • Immunosuppression
  • mid covid-19 patients
  • Jinan, Shandong, China
    Qilu Hospital of Shandong University
Jan 6, 2023

TNBC - Triple-Negative Breast Cancer, Breast Cancer Trial in Worldwide (Trilaciclib, Placebo, Gemcitabine)

Active, not recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Breast Cancer
  • Birmingham, Alabama
  • +111 more
Oct 25, 2022

Response to Influenza Vaccination in Pediatric Oncology Patients

Recruiting
  • Hematologic Malignancy
  • +2 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Oct 17, 2022

    Advanced Malignancies Trial in Worldwide (MBG453, PDR001, Decitabine)

    Terminated
    • Advanced Malignancies
    • Baltimore, Maryland
    • +13 more
    Sep 20, 2022

    Neoadjuvant Therapy in Rectal Cancer

    Recruiting
    • Rectal Cancer
    • Immune checkpoint measure
    • Istanbul, Turkey
      Istanbul Training and Research Hospital
    Jul 9, 2022

    Stroke, Multiple Sclerosis, Parkinson Disease Trial in Lucerne (smart sensor egg training)

    Recruiting
    • Stroke
    • +2 more
    • smart sensor egg training
    • Lucerne, Switzerland
      Luzerner Kantonsspital
    Sep 28, 2023

    Head and Neck Squamous Cell Carcinoma Trial in Candiolo (inulin, Pembrolizumab, Nivolumab)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • inulin
    • +2 more
    • Candiolo, Turin, Italy
      Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo
    Apr 7, 2023

    A Qualitative Investigation of CLEAT Participants

    Not yet recruiting
    • Osteoarthritis
    • Qualitative Investigation of Participant Experiences
    • (no location specified)
    Jul 6, 2023

    LY007 for r/r B-NHL and Exploration of Novel CAR-T Translational

    Not yet recruiting
    • Relapsed Non-Hodgkin Lymphoma
      • (no location specified)
      Sep 19, 2023